Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies
- PMID: 9493684
- DOI: 10.1183/09031936.97.10122907
Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies
Abstract
Interstitial lung disease (ILD) is a complication of polymyositis (PM) and dermatomyositis (DM). It often manifests itself in association with myositis-specific antisynthetase autoantibodies, among which anti-Jo-1 antibodies are the most commonly encountered. In contrast, ILD associated with anti-Jo-1 antibodies without muscle involvement is rare and not well characterized. We report four patients presenting with ILD associated with anti-Jo-1 antibodies. Histological findings of transbronchial biopsies disclosed a pattern consistent with nonspecific interstitial pneumonitis, a CD8+ lymphocytosis was found in bronchoalveolar lavage. Only one of these patients developed an "antisynthetase syndrome" with PM, after nearly 2 yrs of severe ILD. The clinical conditions of all four cases showed stabilization or improvement when cyclosporine was added to their immunosuppressive treatment. These cases confirm that a CD8+ lymphocytic interstitial lung disease may be the first, and sole manifestation of autoimmune disease associated with anti-Jo-1 antibodies. Furthermore, they suggest that this form of interstitial lung disease apparently has a poor response to steroids and cytotoxic drugs, but may respond to moderate doses of cyclosporine and azathioprine in addition to low doses of steroids.
Similar articles
-
Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.Z Rheumatol. 1993 Sep-Oct;52(5):307-11. Z Rheumatol. 1993. PMID: 8259723
-
[The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].Pneumologie. 2010 Aug;64(8):496-503. doi: 10.1055/s-0029-1244054. Epub 2010 Apr 12. Pneumologie. 2010. PMID: 20387195 German.
-
Interstitial lung disease in polymyositis and dermatomyositis.Arthritis Rheum. 2002 Dec 15;47(6):614-22. doi: 10.1002/art.10794. Arthritis Rheum. 2002. PMID: 12522835
-
[Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].Brain Nerve. 2013 Nov;65(11):1275-82. Brain Nerve. 2013. PMID: 24200605 Review. Japanese.
-
Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.Autoimmun Rev. 2012 Mar;11(5):335-40. doi: 10.1016/j.autrev.2011.09.007. Epub 2011 Oct 1. Autoimmun Rev. 2012. PMID: 21985773 Review.
Cited by
-
Pulmonary complications of inflammatory myopathy.Curr Rheumatol Rep. 2002 Oct;4(5):409-14. doi: 10.1007/s11926-002-0086-x. Curr Rheumatol Rep. 2002. PMID: 12217246 Review.
-
The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation.Front Immunol. 2023 Oct 19;14:1288098. doi: 10.3389/fimmu.2023.1288098. eCollection 2023. Front Immunol. 2023. PMID: 37928522 Free PMC article.
-
Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease.J Rural Med. 2020 Oct;15(4):225-229. doi: 10.2185/jrm.2020-018. Epub 2020 Oct 1. J Rural Med. 2020. PMID: 33033547 Free PMC article.
-
Expression of Inflammatory Markers in the Muscles of Patients with Idiopathic Inflammatory Myopathy According to the Presence of Interstitial Lung Disease.J Clin Med. 2022 May 27;11(11):3021. doi: 10.3390/jcm11113021. J Clin Med. 2022. PMID: 35683408 Free PMC article.
-
A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis.Immunology. 2000 Dec;101(4):501-11. doi: 10.1046/j.1365-2567.2000.00143.x. Immunology. 2000. PMID: 11122454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials